MedPath

Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.

Not Applicable
Not yet recruiting
Conditions
Stroke
Interventions
Device: treadmill training
Device: multi-sensory stimulation immersive VR+ treadmill training
Registration Number
NCT06275516
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Brief Summary

This was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.

Detailed Description

This was single-blind randomized controlled intervention study. Each stroke subject underwent screening period, baseline assessment period, intervention period, endpoint assessment period.

The screening period include the verification of inclusion/exclusion criteria and the acquisition of informed consent.

Baseline and endpoint assessment period include motor function related scales were evaluated (muscle strength, muscle tone, Fugl-Meyer scale, Berg balance scale); cognitive function related scale assessment \[Brief Mental State Examination Scale (MMSE), Montreal Cognitive Assessment (MoCA), drawing clock test, Shape connection test A.B, standardized digital modal experiment, auditory word Learning Test\], emotional correlation scale assessment (Hamilton Depression Scale, Hamilton Anxiety Scale), and activity of daily living scale ADL scale. Meanwhile, quantitative evaluation of motor function three-dimensional gait detection and assessment of brain functional activation (fNIRs tests and fMRI) were synchronously completed.

The intervention period included multi-sensory stimulation immersive VR+ treadmill training with suitable for training intensity in the experimental group and only treadmill training similarly with suitable for training intensity in the control group. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).

Preliminary validation of effectiveness assessment includes Fugl-Meyer scale, Berg balance scale, and three-dimensional gait detection. Preliminary validation of the safety assessment includes fall and dizzy incidents.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Diagnosis of stroke by neuroimaging (CT or MRI) assessment
  2. 18-85 years old
  3. Be able to walk with minor assistance
  4. Can tolerate the rehabilitation training of this experiment
  5. First stroke
  6. Be able to follow instructions to complete the test
  7. Patients who signed informed consent
Exclusion Criteria
  1. The test could not be tolerated due to organic disease
  2. There is a serious mental illness resulting in inability to cooperate with or tolerate this test
  3. is participating in another clinical trial involving an investigational drug or physical therapy
  4. Patients who have not signed informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
treadmill training grouptreadmill trainingOnly treadmill training similarly with suitable for training intensity in the control group. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).
VR+treadmill training groupmulti-sensory stimulation immersive VR+ treadmill trainingMulti-sensory stimulation immersive VR+ treadmill training with suitable for training intensity. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).
Primary Outcome Measures
NameTimeMethod
Berg balance scale30 days (Adjust according to the actual situation of patients)

Balance function evaluation

three-dimensional gait detection30 days (Adjust according to the actual situation of patients)

Quantitative motor function assessment

Fugl-Meyer scale30 days (Adjust according to the actual situation of patients)

Motor function assessment

Fall incidents30 days (Adjust according to the actual situation of patients)

Safety assessment

Dizzy incidents30 days (Adjust according to the actual situation of patients)

Safety assessment

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath